Table 2.
Age /Sex | Race | Body mass index | Diagnosis | Previous treat ment | Histology | |
---|---|---|---|---|---|---|
1 | 64 Male | Caucasian | 32 | Bile ducts | 3 | cholangiocarcinoma |
2 | 64 Male | Caucasian | 27 | Brain cancer | 2 | Grade 4 glioblastoma |
3 | 66 Male | Caucasian | 40 | Prostate | 2 | adenocarcinoma |
4 | 87 Male | Caucasian | 37 | Skin cancer | 0 | melanoma |
5 | 67 Male | Caucasian | 24 | Renal cell | 3 | Clear cell |
6 | 65 Male | Caucasian | 27.5 | Pancreatic | 2 | Adenocarcinoma |
7 | 66 Male | Caucasian | 25.5 | Colon cancer | 2 | Adenocarcinoma |
8 | 64 Male | Caucasian | 34 | Thyroid | 2 | Papillary |
9 | 62 Male | Caucasian | 30 | Skin cancer | 2 | Melanoma |
10 | 82 Male | Caucasian | 31 | Parotid gland/Head/neck | 1 | Squamous cell cancer |
11 | 49 Male | Caucasian | 27 | Brain cancer | 2 | Astrocytoma |
12 | 42 Male | Caucasian | 29 | Skin cancer | 2 | Melanoma |
13 | 59 Male | Caucasian | 25 | Head/neck supraglottic | 2 | Squamous cell |
14 | 66 Male | Caucasian | 35 | Liver | 1 | Hepatocellular carcinoma |
15 | 54 Male | Caucasian | 26 | Pancreatic | 0 | Post lung transplant, Adenocarcinoma |
16 | 68 Male | Caucasian | 24 | Lung | 0 | Squamous Non small cell |
17 | 84 Male | Caucasian | 23 | Lung | 0 | Adenocarcinoma Non small cell Stage 4 |